AirSculpt Technologies (AIRS) vs Starling Oncology (STLN)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Starling Oncology (STLN) has outperformed AirSculpt Technologies (AIRS) over the past year, gaining 68.3% versus a loss of 77.3%. Starling Oncology is the larger company by market cap ($655.3 million vs $131.2 million), about 5.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | AIRS | STLN |
|---|---|---|
| Share price | $1.82 | $6.43 |
| Market cap | $131.21M | $655.32M |
| 1-day change | -2.15% | -2.28% |
| YTD return | -8.08% | +80.62% |
| 1-year return | -77.33% | +68.32% |
| 5-year return | — | -35.38% |
| EPS (TTM) | $-0.17 | $-0.28 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $12.00 | $7.13 |
| 52-week low | $1.51 | $2.32 |
| Distance from 52-week high | -84.83% | -9.82% |
| Analyst consensus | none | strong_buy |
| Avg. price target upside | +147.25% | +39.97% |
| Average volume | 825.67K | 1.55M |
| Shares outstanding | 72.10M | 101.92M |
| Employees | 330 | 641 |
| Sector | Healthcare | Healthcare |
| Industry | Medical Care Facilities | Medical Care Facilities |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Starling Oncology is about 5.0 times larger than AirSculpt Technologies by market value ($655.32M vs $131.21M).
- STLN has outperformed AIRS by 145.7 percentage points over the past year.
About AirSculpt Technologies
AIRS stock →AirSculpt Technologies, Inc., together with its subsidiaries, focuses on operating as a holding company for EBS Intermediate Parent LLC that provides body contouring procedure services in the United States and Canada. The company offers AirSculpt, a body contouring treatment that removes fat and tightens skin while sculpting targeted areas of the body in a minimally invasive procedure.
Healthcare · Medical Care Facilities · 330 employees
About Starling Oncology
STLN stock →Starling Oncology, Inc., an oncology company, provides various oncology services in the United States. It operates through three segments: Specialty pharmacy, Patient Services, and Clinical Trials & Other.
Healthcare · Medical Care Facilities · 641 employees
AIRS vs STLN FAQ
Which is bigger, AirSculpt Technologies or Starling Oncology?
Starling Oncology (STLN) is larger, with a market capitalization of $655.32M compared with $131.21M for AirSculpt Technologies (AIRS).
Which stock has performed better over the past year, AIRS or STLN?
STLN returned +68.32% over the past 12 months, compared with -77.33% for AIRS (price return, excluding dividends). Past performance does not predict future results.
Are AirSculpt Technologies and Starling Oncology in the same industry?
Yes. Both are classified in the Medical Care Facilities industry within the Healthcare sector.